{
  "patient_details": {
    "name": "piyush",
    "age": 30,
    "gender": "Male",
    "symptoms": "Hematuria, Proteinuria, Edema, High blood pressure, Flank pain, Lower back pain, Fatigue, Changes in urine color, Uremia, Nausea, Vomiting, Loss of appetite",
    "duration": "2 years",
    "family_history": "No",
    "medications": "No",
    "previous_diagnoses": "no",
    "travel": "yes, India, Dubai",
    "allergies": "no",
    "other_conditions": "no"
  },
  "top_rare_diseases": [
    {
      "disease_name": "Nephrotic Syndrome",
      "score": 0.92,
      "description": "A kidney disorder characterized by excessive excretion of protein in the urine, leading to complications such as edema and high blood pressure.",
      "overview": "Nephrotic syndrome is a collection of symptoms due to kidney damage. This includes proteinuria, hypoalbuminemia, and edema.",
      "signs_symptoms": [
        "Proteinuria",
        "Hematuria",
        "Edema",
        "High blood pressure",
        "Fatigue",
        "Changes in urine color",
        "Loss of appetite",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "Nephrotic syndrome is a significant condition that can progress to chronic kidney disease and end-stage renal disease if left untreated.",
      "causes": "Glomerular diseases (e.g., minimal change disease, focal segmental glomerulosclerosis), infections, drugs, systemic diseases (e.g., lupus)",
      "related_disorders": [
        "Nephritic Syndrome",
        "Chronic Kidney Disease",
        "Lupus Nephritis",
        "Membranous Nephropathy"
      ],
      "diagnosis": "Urine tests (proteinuria, hematuria), blood tests (serum albumin, cholesterol), kidney biopsy",
      "treatment": "ACE inhibitors, ARBs, corticosteroids, immunosuppressants, diuretics, dietary modifications",
      "clinical_trials": [
        "Trial of Spironolactone in Nephrotic Syndrome (ClinicalTrials.gov)",
        "Efficacy of Rituximab in Steroid-Resistant Nephrotic Syndrome (ClinicalTrials.gov)"
      ],
      "key_aspects": [
        "Excessive proteinuria",
        "Edema and hypoalbuminemia",
        "Associated with various glomerular and systemic diseases",
        "Requires immunosuppressive therapy in steroid-resistant cases"
      ]
    },
    {
      "disease_name": "IgA Nephropathy",
      "score": 0.89,
      "description": "A kidney disease characterized by the deposition of IgA antibodies in the glomeruli, leading to inflammation and kidney damage.",
      "overview": "IgA Nephropathy, also known as Berger's disease, is the most common cause of kidney disease worldwide and can progress to chronic kidney disease.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Flank pain",
        "Lower back pain",
        "High blood pressure",
        "Edema",
        "Changes in urine color"
      ],
      "clinical_significance": "IgA Nephropathy can lead to end-stage renal disease in some patients, requiring dialysis or kidney transplantation.",
      "causes": "Deposition of IgA antibodies in the kidneys, genetic predisposition, infections, mucosal infections",
      "related_disorders": [
        "Henoch-Sch\u00f6nlein Purpura",
        "Chronic Kidney Disease",
        "Lupus Nephritis",
        "Focal Segmental Glomerulosclerosis"
      ],
      "diagnosis": "Urine tests (blood and protein in urine), blood tests (IgA levels), kidney biopsy",
      "treatment": "ACE inhibitors, ARBs, corticosteroids, immunosuppressants, tonsillectomy in some cases",
      "clinical_trials": [
        "Trial of Omega-3 Fatty Acids in IgA Nephropathy (ClinicalTrials.gov)",
        "Efficacy of Rituximab in IgA Nephropathy (ClinicalTrials.gov)"
      ],
      "key_aspects": [
        " deposition of IgA in glomeruli",
        "Often presents with hematuria following upper respiratory infections",
        "Variable prognosis, with some progressing to ESRD",
        "Treatments focus on reducing proteinuria and inflammation"
      ]
    },
    {
      "disease_name": "Alport Syndrome",
      "score": 0.85,
      "description": "A genetic disorder characterized by glomerulonephritis, end-stage kidney disease, and hearing loss.",
      "overview": "Alport Syndrome is a hereditary disease caused by mutations in type IV collagen genes, leading to progressive kidney disease and hearing loss.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Flank pain",
        "Lower back pain",
        "High blood pressure",
        "Edema",
        "Changes in urine color",
        "Hearing loss",
        "Vision abnormalities"
      ],
      "clinical_significance": "Alport Syndrome is a progressive disease that often leads to end-stage renal disease and hearing loss.",
      "causes": "Genetic mutations in COL4A3, COL4A4, COL4A5 genes",
      "related_disorders": [
        "Chronic Kidney Disease",
        "Lupus Nephritis",
        "Goodpasture Syndrome",
        "Hereditary Nephritis"
      ],
      "diagnosis": "Family history, urine tests, blood tests, genetic testing, kidney biopsy",
      "treatment": "ACE inhibitors, ARBs, management of chronic kidney disease, dialysis, kidney transplantation",
      "clinical_trials": [
        "Trial of Anti-TGF-\u03b2 Therapy in Alport Syndrome (ClinicalTrials.gov)",
        "Efficacy of ACE Inhibitors in Slowing Progression (ClinicalTrials.gov)"
      ],
      "key_aspects": [
        "Genetic disorder with family history",
        "Associated with hearing loss and eye abnormalities",
        "Progressive kidney disease leading to ESRD",
        "No specific cure, management focuses on slowing progression"
      ]
    },
    {
      "disease_name": "Membranous Nephropathy",
      "score": 0.83,
      "description": "A kidney disease characterized by the thickening of the glomerular basement membrane, leading to proteinuria and kidney damage.",
      "overview": "Membranous Nephropathy is an immune-mediated disease that can be primary (idiopathic) or secondary to other conditions.",
      "signs_symptoms": [
        "Proteinuria",
        "Hematuria",
        "Edema",
        "High blood pressure",
        "Changes in urine color",
        "Fatigue",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "Membranous Nephropathy can progress to chronic kidney disease and end-stage renal disease if untreated.",
      "causes": "Autoimmune causes (antibodies to PLA2R), secondary to infections, drugs, systemic diseases (e.g., lupus)",
      "related_disorders": [
        "Nephrotic Syndrome",
        "Lupus Nephritis",
        "Chronic Kidney Disease",
        "Focal Segmental Glomerulosclerosis"
      ],
      "diagnosis": "Urine tests (proteinuria), blood tests (antibodies), kidney biopsy",
      "treatment": "ACE inhibitors, ARBs, corticosteroids, immunosuppressants, Rituximab, dietary modifications",
      "clinical_trials": [
        "Trial of Rituximab in Membranous Nephropathy (ClinicalTrials.gov)",
        "Efficacy of Anti-PLA2R Antibodies Therapy (ClinicalTrials.gov)"
      ],
      "key_aspects": [
        "Primary or secondary causes",
        "Presence of antibodies to PLA2R in idiopathic cases",
        "Variable response to immunosuppressive therapy",
        "Relapses are common after initial treatment"
      ]
    },
    {
      "disease_name": "Lupus Nephritis",
      "score": 0.81,
      "description": "A complication of systemic lupus erythematosus (SLE) affecting the kidneys and leading to inflammation and damage.",
      "overview": "Lupus Nephritis is a common and serious complication of SLE, leading to kidney inflammation and potential organ failure.",
      "signs_symptoms": [
        "Proteinuria",
        "Hematuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Changes in urine color",
        "Fatigue",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "Lupus Nephritis is a major predictor of poor outcomes in SLE patients, necessitating prompt treatment.",
      "causes": "Autoimmune response, immune complex deposition in kidneys",
      "related_disorders": [
        "Systemic Lupus Erythematosus (SLE)",
        "Chronic Kidney Disease",
        "Nephrotic Syndrome",
        "IgA Nephropathy"
      ],
      "diagnosis": "Urine tests (proteinuria, hematuria), blood tests (ANAs, complement levels), kidney biopsy",
      "treatment": "Corticosteroids, immunosuppressants (e.g., cyclophosphamide, mycophenolate), hydroxychloroquine, ACE inhibitors",
      "clinical_trials": [
        "Trial of Belimumab in Lupus Nephritis (ClinicalTrials.gov)",
        "Efficacy of Voclosporin in Lupus Nephritis (ClinicalTrials.gov)"
      ],
      "key_aspects": [
        "Associated with Systemic Lupus Erythematosus",
        "Immune complex deposition in kidneys",
        "Requires aggressive immunosuppressive therapy",
        "Regular monitoring for disease flare-ups and kidney function"
      ]
    }
  ]
}